Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-25 @ 1:41 AM
NCT ID:
NCT01490294
Eligibility Criteria:
Inclusion Criteria:
* Males or females of any ethnic group with reversible focal hypoperfusion in at least 2 adjoining segments in SPECT
* The SPECT examination had been performed within 4 weeks prior to the MRI examination and had been performed for clinical reasons only
Exclusion Criteria:
* Generalized myocardial hypoperfusion (e.g. severe 3 vessel disease)
* Recent myocardial infarction (MI) (within 1 week prior to the study procedure)
* Event that significantly altered cardiac performance between SPECT and MRI imaging, e.g. myocardial infarction, unstable angina, alteration of cardiac medication
* Non-sinus rhythm
* Sinus node disease or symptomatic bradycardia
* Second or third degree atrial ventricular (AV) block
* Complete left bundle branch block (LBBB)
* Known congenital long QT syndrome or a family history of congenital long QT syndrome
* Known previous arrhythmias on drugs that prolong cardiac repolarization
* Uncorrected hypokalemia
* Uncontrolled hypertension (e.g. systolic blood pressure \>185 mm Hg, diastolic blood pressure \>110 mm Hg)
* Baseline hypotension (e.g. mean arterial pressure \<60 mm Hg)
* Ejection fraction below 35%
* Cardiomyopathy, congenital heart defect or higher degree valvular pathology
* Coronary artery stent placement within 4 weeks prior to the MRI procedure
* Previous heart transplantation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01490294
Study Brief:
Protocol Section:
NCT01490294